https://www.selleckchem.com/pr....oducts/lonafarnib-sc
Results Baseline physiologic data and basic labs were similar between groups. Compared to control, interventions similarly prolonged survival from a median of 18 to over 240 minutes with comparable mortality trends. Blood loss was similar between partial ER-REBOA (41%) and pREBOA-PRO (51%). Partial pREBOA-PRO required a significantly lower number of intra-aortic balloon adjustments (10 ER-REBOA vs. 3 pREBOA-PRO, p less then 0.05) to maintain the target below-the-balloon MAP. The partial ER-REBOA group developed significantly
Like
Comment
Share
